Journal article
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines
JML Brotherton, M Jit, PE Gravitt, M Brisson, AR Kreimer, SI Pai, C Fakhry, J Monsonego, S Franceschi
International Journal of Cancer | WILEY | Published : 2016
DOI: 10.1002/ijc.30063
Abstract
This review is one of two complementary reviews that have been prepared in the framework of the Eurogin Roadmap 2015 to evaluate how knowledge about HPV is changing practices in HPV infection and disease control through vaccination and screening. In this review of HPV vaccine knowledge, we present the most significant findings of the past year which have contributed to our knowledge of the two HPV prophylactic vaccines currently in widespread use and about the recently licensed nonavalent HPV vaccine. Whereas anal cancer is dealt with in the companion mini-review on screening, we also review here the rapidly evolving evidence regarding HPV-associated head and neck cancer and priority researc..
View full abstractGrants
Awarded by National Institute of Dental and Craniofacial Research
Funding Acknowledgements
JMLB has been an investigator on investigator designed unrestricted epidemiological research grants partially funded through bioCSL/Merck but has received no personal financial benefits. In the past 3 years, MB received an unrestricted grant from Merck Frosst related to Zoster burden of illness (no grants ongoing). JM reports having received honorarium as a member of the scientific advisory board of Sanofi Pasteur MSD, Merck, Roche Diagnostics, Gen-Probe and Genticel and compensation from Merck and Glaxo Smith Kline to conduct vaccine trials.